Article
Sertad4 regulates pathological cardiac remodeling.
2026-03-20
Abstract excerpt
Cardiac fibrosis driven by persistent myofibroblast activation is a major contributor to adverse ventricular remodeling and heart failure. Bromodomain and extra-terminal domain (BET) inhibition reduces fibrosis and hypertrophy in preclinical models, but direct targeting of the BET co-activator BRD4 is limited by family homology and potential systemic toxicity. Sertad4 (SERTA domain containing protein 4) is a BRD4-...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 341d74c0-8f74-5b8f-b7a9-397bb6146bd6
- DOI
- 10.64898/2026.03.18.708586
